Literature DB >> 18600553

Cytoprotective effects of nicotinamide derivatives in endothelial cells.

E M Slominska1, A Yuen, L Osman, J Gebicki, M H Yacoub, R T Smolenski.   

Abstract

Following discovery of NAD(+)-dependent reactions that control gene expression, cytoprotection, and longevity, there has been a renewed therapeutic interest in precursors, such as nicotinamide and its derivatives. We tested 20 analogues of nicotinamide for their ability to protect endothelial cells from peroxynitrite stress and their effect on poly (ADP-ribose) polymerase (PARP) activity. Several nicotinamide derivatives protected endothelial cells from peroxynitrite-induced depletion of cellular NAD(+) and ATP concentrations, but only some of these compounds inhibited PARP. We conclude that some nicotinamide derivatives provide protection of endothelial cells against peroxynitrite-induced injury independent of inhibition of PARP activity. Preservation of the NAD(+) pool was a common effect of these compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600553     DOI: 10.1080/15257770802146528

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  9 in total

Review 1.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

2.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

3.  N-[2-(4-Bromo-phen-yl)-5-methyl-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide.

Authors:  Mehmet Akkurt; Ismail Celik; Hale Demir; Sumru Ozkırımlı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-19

4.  N-[5-Methyl-2-(2-nitro-phen-yl)-4-oxo-1,3-thia-zolidin-3-yl]pyridine-3-carboxamide monohydrate.

Authors:  Mehmet Akkurt; Ismail Celik; Hale Demir; Sumru Ozkırımlı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-08

5.  3-Ethyl-5-(4-meth-oxy-phen-oxy)-2-(pyridin-4-yl)-3H-imidazo[4,5-b]pyridine.

Authors:  S Ranjith; A Subbiahpandi; A D Suresh; K Pitchumani
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-22

6.  The Biochemical Pathways of Nicotinamide-Derived Pyridones.

Authors:  Faisal Hayat; Manoj Sonavane; Mikhail V Makarov; Samuel A J Trammell; Pamela McPherson; Natalie R Gassman; Marie E Migaud
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

7.  8-Furylimidazolo-2'-deoxycytidine: crystal structure, packing, atropisomerism and fluorescence.

Authors:  Simone Budow-Busse; Sunit K Jana; Dasharath Kondhare; Constantin Daniliuc; Frank Seela
Journal:  Acta Crystallogr C Struct Chem       Date:  2022-02-09       Impact factor: 1.172

Review 8.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

Review 9.  What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.

Authors:  Raymond Vanholder; Sanjay K Nigam; Stéphane Burtey; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2022-03-17       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.